While patient studies have provided strong evidence for the importance of SPINK1 across different tumor types, the regulatory pathways that control SPINK1 expression and the direct targets of SPINK1 in the context of the tumor microenvironment, including both protease target(s) and cell surface receptor(s), remain largely unknown. Here, SPINK1 is linked to neoplasm.